Abstract:Photodynamic therapy (PDT) has emerged as a powerful candidate for cancer intervention as for the merits of least-invasiveness, multidrug resistance-free and spatiotemporal selectivity. Whereas, clinical photosensitizers (PSs) suffer from microsecond-level reactive oxygen species (ROS) lifetime requiring 20–30 min continuous exterior light stimulation, deficient photostable nature and off-target phototoxicity in nonmalignant tissues. Persistent luminescence nanoparticles (PLNPs), are proven to exert long-lasting ROS production after the excitation cessation (hours to days), and serve as photostable imaging agent for diagnose. Herein, a traceable theranostic agent, ZP@PCM PLNPs is prepared by modifying polyaniline (PANI) onto Zn 1.2 Ga 1.6 Ge 0.2 O 4 : Cr 3+ (ZGGC) to obtain ZP PLNPs and wrapping phase-change material (PCM) as outer protective shell. Solid-phase PCM isolates inner ZP PLNPs from surrounding oxygen during circulation to circumvent off-target photosensitization. Once ZP@PCM PLNPs accumulated within tumors, external laser triggered PANI assisted photothermal therapy (PTT) initiates, and thermal melting of PCM shell occurs leading to the exposure of ZP PLNPs to switch on PDT. PANI also facilitates PDT efficacy optimization, enabling ZP PLNPs of 2-fold ROS yield compared to ZGGC PLNPs, sustained up to 48 h upon 10 min of illumination. ZP@PCM PLNPs with long-term, moderate therapy modality presents ameliorated anti-tumor effect, achieving tumor inhibition rate of 92.2 % over that of ∼ 46 % with individual ZGGC PLNPs, and shows satisfactory biosafety without tissues damage or inflammatory response. Meanwhile, the autofluorescence-free visualization potency helps to self-report therapeutic outcomes and determine treatment duration. Overall, ZP@PCM PLNPs provide a promising PSs-free alternative candidate for finely controlled PDT/PTT and visualization tumor therapy.

Revealing Excited-State Dynamics of Type I Zinc Phthalocyanine Photosensitizer for Photodynamic Therapy

Theoretical Insights on Type I/II Photoreactions of Potential Zn(II) Polypyridyl Photosensitizers for Two-Photon Photodynamic Therapy

Phthalocyanine-based coordination polymer nanoparticles for enhanced photodynamic therapy.

Improved Photodynamic Anticancer Activity and Mechanisms of a Promising Zinc(ii) Phthalocyanine-Quinoline Conjugate Photosensitizer in Vitro and in Vivo.

Synthesis and Type I/Type II photosensitizing properties of a novel amphiphilic zinc phthalocyanine

Photocyanine: A Novel and Effective Phthalocyanine-Based Photosensitizer for Cancer Treatment

Synthesis of Asymmetric Cationic Zinc Porphyrin Photosensitizer Containing Thiophene Group for Photodynamic Therapy in Vitro and Theoretical Calculation of DFT

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

Phthalocyanine-Assembled Nanodots As Photosensitizers for Highly Efficient Type I Photoreactions in Photodynamic Therapy

Quinolin-8-yloxy-substituted zinc(II) phthalocyanines for enhanced in vitro photodynamic therapy

Type‐I photodynamic therapy induced by Pt‐coordination of type‐II photosensitizers into supramolecular complexes

Photophysical Exploration of Zn(II) Polypyridine Photosensitizers in Two-Photon Photodynamic Therapy: Insights from Theory

A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy

Highly Efficient Photosensitizers with Molecular Vibrational Torsion for Cancer Photodynamic Therapy

Probing the Interactions of Phthalocyanine-Based Photosensitizers with Model Phospholipid Bilayer by Molecular Dynamics Simulations

Photosensitizer-Free Nanophosphor-Based theranostic probe for controllable photodynamic and photothermal visualization therapy

Molecular Engineering Design of Twisted-backbone Pure Type-I Organic Photosensitizers for Hypoxic Photodynamic Therapy

A Design Strategy of Pure Type-I Thiadiazolo[3,4-G]quinoxaline-based Photosensitizers for Photodynamic Therapy

Bioinspired Design of Seco‐chlorin Photosensitizers to Overcome Phototoxic Effects in Photodynamic Therapy

In Vitro Photodynamic Activities of Zinc(ii) Phthalocyanines Substituted with Pyridine Moieties.

Construction of Type I Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy Via Photoinduced Electron Transfer Mechanism